Contrast Media & Molecular Imaging
© John Wiley & Sons Ltd
Co Editor-in-Chief: Silvio Aime & Robert N. Muller
Impact Factor: 3.286
ISI Journal Citation Reports © Ranking: 2015: 22/124 (Radiology Nuclear Medicine & Medical Imaging)
Online ISSN: 1555-4317
Associated Title(s): NMR in Biomedicine
Recently Published Issues
CMMI publishes Special ENCITE Issue
The European Network for Cell Imaging and Tracking Expertise (ENCITE) was an EC-funded project involving 29 project partners from 11 countries. Together, researchers from a diverse array of disciplines developed new MR and optical imaging methods and biomarkers to acquire a more comprehensive picture of cell fate, and to ultimately improve and further develop cell therapy for the benefit of the European patient.
CMMI shows videos
An increasing number of articles feature videos or simulations of experiments.
One of the latest examples in CMMI is the movie in the Supporting Information part of
Real-time 3D MRI of contrast agents in whole living mice
[DOI: 10.1002/cmmi.429] by S Miraux et al
Wiley and Hindawi partnership
Contrast Media & Molecular Imaging is part of an exciting new pilot partnership between Wiley and Hindawi. From 1st January 2017, the journal will become fully open access. Contrast Media & Molecular Imaging will remain a Wiley title but will be published and hosted by Hindawi, and will benefit from Hindawi’s experience and expertise in publishing open access titles. Contrast Media & Molecular Imaging will continue to undergo a rigorous peer review process ensuring that quality remains high. Manuscripts submitted on or after 16 June 2016 and accepted for publication will be published as open access articles, immediately free to read, download and share. Authors or their funder will be required to pay an Article Publication Charge upon acceptance. For further information, please click here
Find out about the journal’s open access option with OnlineOpen.